跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PULMICORT Respules budesonide 0.125mg/mL nebuliser suspension - TGA Drug Approval Details
Approvals
/
TGA
/
PULMICORT Respules budesonide 0.125mg/mL nebuliser suspension
Approved
STANDARD
PULMICORT Respules budesonide 0.125mg/mL nebuliser suspension
AstraZeneca Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
abef496e430ae797
Company
AstraZeneca Pty Ltd
Type
Standard
Approval Details
Approval Id
abef496e430ae797
Product Name
PULMICORT Respules budesonide 0.125mg/mL nebuliser suspension
Artg Id
297787
Artg Name
PULMICORT Respules budesonide 0.125mg/mL nebuliser suspension
Sponsor
AstraZeneca Pty Ltd
Company Detail Path
/organization/astrazeneca-pty-ltd
Artg Date
2017-12-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
abef496e430ae797
Type
Standard
Back to TGA Approvals
